COMMUNIQUÉS West-GlobeNewswire

Ozempic® (semaglutide) recommended for approval by the European regulatory authorities
15/12/2017
Bagsværd, Denmark, 15 December 2017 - Novo Nordisk today announced that the Committee for Medicinal Products for Human Use (CHMP) under the European Medicines Agency (EMA) has adopted a positive opinion, recommending [...]
Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn's disease
15/12/2017
PRESS RELEASE REGULATED INFORMATION INSIDE INFORMATION Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn's disease First allogeneic [...]
Takeda et TiGenix annoncent que le Cx601 (darvadstrocel) a reçu la décision favorable du CHMP dans le traitement des fistules périanales complexes de la maladie de Crohn
15/12/2017
COMMUNIQUE DE PRESSE INFORMATION REGLEMENTEE CONNAISSANCE PREALABLE Takeda et TiGenix annoncent que le Cx601 (darvadstrocel) a reçu la décision favorable du CHMP dans le traitement des fistules périanales complexes de [...]
Sanofi: FDA lifts clinical hold on fitusiran
15/12/2017
Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) FDA lifts clinical hold on fitusiran Clinical trial dosing to resume around year-end 2017 Paris and Cambridge, Mass. - December 15, 2017 - Sanofi Genzyme , the [...]
Sanofi : La FDA lève la suspension des essais cliniques consacrés au fitusiran
15/12/2017
Communiqué de presse Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) La FDA lève la suspension des essais cliniques consacrés au fitusiran L'administration de ce médicament dans le cadre des essais cliniques qui lui sont [...]
Ohr Pharmaceutical Reports Fiscal Year 2017 Financial Results
15/12/2017
Management to Host a Conference Call and Webcast at 8:30 a.m. Eastern Time Today NEW YORK, Dec. 15, 2017 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq: OHRP ), a clinical-stage pharmaceutical company developing [...]
Aclaris Therapeutics Receives FDA Approval for ESKATA™ (Hydrogen Peroxide) Topical Solution, 40% (w/w) for the Treatment of Raised Seborrheic Keratoses (SKs)
15/12/2017
ESKATA™ is the First and Only FDA-Approved Topical, Non-invasive Treatment for Raised SKs; Management to Hold Conference Call at 8:00 AM ET Today MALVERN, Pa., Dec. 15, 2017 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc [...]
TESARO Announces Availability of ZEJULA® (niraparib) for Women With Recurrent Ovarian Cancer in Germany
15/12/2017
ZEJULA is the first PARP inhibitor approved in Europe for women with recurrent ovarian cancer, without the need for BRCA testing and regardless of biomarker status ZEJULA is the only PARP inhibitor to offer once-daily, [...]
Employers, Health Plans and Providers Endorse Initiative to Standardize Performance Measures for Commercial Accountable Care Organizations (ACOs) in California
15/12/2017
OAKLAND, Calif., Dec. 15, 2017 (GLOBE NEWSWIRE) -- In an effort to collect more meaningful quality and cost information and reduce burden on clinicians, leading California health care purchasers, plans and providers [...]
Novartis announces Oncology head to retire
15/12/2017
Basel, December 15, 2017 - Novartis announced today that Bruno Strigini, CEO Novartis Oncology has decided to retire from Novartis and the industry for personal reasons. Joseph Jimenez, CEO of Novartis, said: "I'd like [...]
Beleave Provides Business Update
15/12/2017
TORONTO, Dec. 14, 2017 (GLOBE NEWSWIRE) -- Beleave Inc. (" Beleave " or the " Company ") (CSE:BE) (OTCQX:BLEVF) is pleased to announce that it has received notification from Health Canada that, upon the Company's [...]
Mesoblast grants TiGenix an exclusive global patent license to use adipose-derived mesenchymal stem cells in the local treatment of fistulae
15/12/2017
NEW YORK and MELBOURNE, Australia and LEUVEN, Belgium, Dec. 14, 2017 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB) (Nasdaq: MESO ) and TiGenix NV (Euronext Brussels:TIG) (Nasdaq: TIG ) today announce that Mesoblast [...]
Resverlogix Announces Filing of Quarterly Financial Statements and Management’s Discussion & Analysis
15/12/2017
CALGARY, Alberta, Dec. 14, 2017 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the "Company") (TSX: RVX ) announced today that it has filed its unaudited interim Consolidated Financial Statements and Management [...]
Mesoblast grants TiGenix an exclusive global patent license to use adipose-derived mesenchymal stem cells in the local treatment of fistulae
15/12/2017
PRESS RELEASE REGULATED INFORMATION INSIDE INFORMATION Mesoblast grants TiGenix an exclusive global patent license to use adipose-derived mesenchymal stem cells in the local treatment of fistulae New York, USA, [...]
INC Research/inVentiv Health to Present at Upcoming J.P. Morgan Healthcare Conference
15/12/2017
RALEIGH, N.C., Dec. 14, 2017 (GLOBE NEWSWIRE) -- INC Research/inVentiv Health (Nasdaq: INCR ), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive Officer Alistair [...]
Galena Will Adjourn Special Meeting until Friday, December 29, 2017, Urges Stockholders to Vote
14/12/2017
SAN RAMON, Calif., Dec. 14, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ: GALE ), (“ Galena ”) announced today that its special meeting of stockholders (“ Special Meeting ”), scheduled for December 15, 2017, [...]
iKang Announces Unaudited Financial Results for the Fiscal Second Quarter Ended September 30, 2017
14/12/2017
BEIJING, Dec. 14, 2017 (GLOBE NEWSWIRE) -- iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG ), a major provider in China’s fast growing private preventive healthcare services market, today announced [...]
BioDelivery Sciences Reacquires ONSOLIS® from Collegium Pharmaceutical
14/12/2017
RALEIGH, N.C., Dec. 14, 2017 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI ) announced that it has received the required 90-day notice from Collegium Pharmaceutical, Inc. regarding [...]
Wright Medical Group N.V. Announces Acquisition of IMASCAP SAS
14/12/2017
Ensures Exclusive Access to Breakthrough Software Enabling Technology to Further Differentiate Wright’s Product Portfolio and Further Accelerate Growth Opportunities in Wright’s Global Extremities Business Purchase [...]

Pages